MYTESI

This brand name is authorized in United States.

Active ingredients

The drug MYTESI contains one active pharmaceutical ingredient (API):

`1`	Crofelemer UNII `PY79D6C8RX` - CROFELEMER
	Crofelemer is an inhibitor of both the cyclic adenosine monophosphate (cAMP)-stimulated cystic fibrosis transmembrane conductance regulator (CFTR) chloride ion (Cl¯) channel, and the calcium-activated Cl¯ channels (CaCC) at the luminal membrane of enterocytes.
	Read more about Crofelemer

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYTESI Delayed-release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	70564-802

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.